跳至主要内容
临床试验/NCT02419703
NCT02419703终止不适用

The STAR™ Tumor Ablation Registry

Merit Medical Systems, Inc.15 个研究点 分布在 1 个国家目标入组 65 人开始时间: 2015年10月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
65
试验地点
15
主要终点
Pain relief (Numerical Rating Pain Scale), post t-RFA

研究概览

简要总结

Registry collecting data on use of The STAR™ Tumor Ablation System.

详细描述

The STAR Prospective Registry is an observational registry to gather clinical safety and outcome data in patients with painful spinal metastases in the thoracolumbar spine (T1-L5) following targeted radiofrequency ablation (t-RFA) treatment with the STAR™ Tumor Ablation System.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects with painful spinal metastatic lesions in thoracolumbar vertebrae (T1-L5) that will be treated with t-RFA using the STAR™ Tumor Ablation System.
  • Have signed informed consent

排除标准

  • Subjects under 18 years old
  • Subjects with heart pacemakers, or other electronic device implants
  • Subjects intended for t-RFA in vertebral body levels C1-7

结局指标

主要结局

Pain relief (Numerical Rating Pain Scale), post t-RFA

时间窗: 1 month

measured by Numerical Rating Pain Scale (NRPS, 0-10 scale)

次要结局

  • Pain & Quality of Life Improvement (measured by the FACT G7 & Numerical Rating Pain Scale)(1 week, 1 month, 3 month, 6 month, 12 month)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (15)

Loading locations...

相似试验